CD24 Expression as a Marker for Predicting Clinical Outcome in Human Gliomas
Figure 1
Immunohistochemical staining of CD24 protein in tumor cells of high-grade glioma (a) and nonneoplastic brain (b) tissues (original magnification ×400). Staining for this antigen is described in Section 2. Positive staining of CD24 is seen in the cytoplasm and membrane of tumor cells in gliomas, whereas the nonneoplastic brain tissues showed no expression of CD24.
